PUBLICACIÓN

Use of pharmacogenetics in bioequivalence studies to reduce sample size: An example with mirtazapine and CYP2D6

ACCEDER A LA PUBLICACIÓN: Scopus Orcid

González-Vacarezza, N., Abad-Santos, F., Carcas-Sansuan, A., Dorado, P., Peñas-Lledó, E., Estévez-Carrizo, F., Llerena, A.

2013 PHARMACOGENOMICS JOURNAL

Genetics (Q2), Molecular Medicine (Q2), Pharmacology (Q1)

JCR: 5.513

SJR: 1.503


CITAS

12

DOI

10.1038/tpj.2012.29

EID

2-s2.0-84884595239

ISSN

1470-269X

EISSN

1473-1150

BIBTEX

@article{Dorado2013,title = {Use of pharmacogenetics in bioequivalence studies to reduce sample size: An example with mirtazapine and CYP2D6},journal = {Pharmacogenomics Journal},year = {2013},volume = {13},number = {5},pages = {452-455},author = {Gonz{\'a}lez-Vacarezza, N. and Abad-Santos, F. and Carcas-Sansuan, A. and Dorado, P. and Pe{\~n}as-Lled{\'o}, E. and Est{\'e}vez-Carrizo, F. and Llerena, A.}}


AUTORES DE LA UEX